Latest Non-steroidal anti-inflammatory drug Stories
SEOUL, South Korea, Oct. 6 /PRNewswire/ -- CrystalGenomics, Inc.
A phase II clinical trial of the first new type of drug for musculoskeletal pain since aspirin shows that it significantly reduces knee pain in osteoarthritis, the most common osteoarthritis pain.
NASHVILLE, Tenn., Sept. 23 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that CaldolorÂ® (ibuprofen) Injection is gaining momentum and being approved for use in a growing number of medical facilities across the country. Several key U.S.
A research team from the University of California, Davis and Peking University, China, has discovered a novel mechanism as to why the long-term, high-dosage use of the well-known arthritis pain medication, Vioxx, led to heart attacks and strokes.
NASHVILLE, Tenn., Aug. 30 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of new data supporting the safety and efficacy of CaldolorÂ® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients.
TARRYTOWN, N.Y., June 9 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc.
People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.
Cost-effectiveness studies are widely used to guide prescribing policy in many countries, as part of health technology assessment programs.
Provides lessons for post-market pharmaceutical safety.
Indomethacin has been proved by epidemiological and experimental studies to be closely associated with peptic ulcer development.
- A serpent whose bite was fabled to produce intense thirst.